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ABSTRACT 
Aims: Whilst much data exists for the effects of flavonoid-rich foods on spatial memory in rodents, there 
are no such data for foods/beverages predominantly containing hydroxycinnamates and phenolic acids.  To 
address this we investigated the effects of moderate Champagne wine intake, which is rich in these 
components, on spatial memory and related mechanisms relative to alcohol- and energy-matched controls. 
Results: In contrast to the iso-caloric and alcohol matched controls, supplementation with champagne wine 
(1.78 ml/kg BW, alcohol 12.5 % vol.) for 6 weeks led to an improvement in spatial working memory in aged 
rodents.  Targeted protein arrays indicated that these behavioral effects were paralleled by the differential 
expression of a number of hippocampal and cortical proteins (relative to the iso-caloric control group), 
including those involved in signal transduction, neuroplasticity, apoptosis and cell cycle regulation. Western 
immunoblotting confirmed the differential modulation of BDNF, CREB, p38, dystrophin, CNPase, mTOR, 
Bcl-xL in response to champagne supplementation compared to the control drink, and the modulation of 
mTOR, Bcl-xL and CREB in response to alcohol supplementation. Innovation: Our data suggest that 
smaller phenolics such as gallic acid, protocatechuic acid, tyrosol, caftaric acid and caffeic acid, in addition 
to flavonoids, are capable of exerting improvements in spatial memory via the modulation in hippocampal 
signalling and protein expression.  Conclusion: Changes in spatial working memory induced by 
Champagne supplementation are linked to the effects of absorbed phenolics on cytoskeletal proteins, 
neurotrophin expression and the effects of alcohol on the regulation of apoptotic events in hippocampus 
and cortex. 
 
  
Corona et al. 
 
3 
INTRODUCTION 
Declines in both cognitive and motor performance due to structural- and activity-related changes in neuronal 
and glial function are known to occur during normal aging (15). Recently, flavonoid containing 
foods/beverages have received much attention with regards to their neuroprotective effects (51), including 
a potential to protect neurons against neurotoxin-induced injury (42, 66), suppress neuroinflammation (59), 
and promote memory and learning (31, 44, 47, 62). In addition to this, numerous epidemiological studies 
have reported that a low to moderate intake of wine (1-2 glasses per day), which is also rich in flavonoids, 
may reduce the risk of coronary heart disease, ischemic stroke, dementia and cognitive impairment (26, 
28, 29, 39).  As such, there is an interest in the potential of regular, moderate wine consumption to 
counteract normal brain ageing and in improving memory and learning, through their potential to deliver 
relatively high amounts of flavonoids (8, 10).  However, although red wines contain high levels of flavonoids 
and other phenolics relative to white wines (33), Champagne wine is relatively rich in phenolic compounds 
(68) such as hydroxybenzoic acids, hydroxycinnamic acids (and their tartaric derivative esters), phenolic 
alcohols and phenolic aldehydes (6).  The increased levels of phenolics in Champagne wine compared to 
other white wines, derive predominantly from the two red grapes, Pinot Noir and Pinot Meunier, which are 
used in its production along with the white grape Chardonnay (9).  As such, it is hypothesized that 
Champagne may deliver significant quantities of phenolics, which may in turn be capable of driving vascular 
and neuronal effects capable of mediating changes in cognitive performance.  
Previously, Champagne wine consumption has been observed to improving acute vascular function (64), 
in a similar manner to that of red wine (7, 12).  Furthermore, tyrosol, caffeic acid, and gallic acid, phenolic 
compounds found at relatively high concentrations in Champagne, have been shown to potently inhibit 
peroxynitrite-induced cellular injury at physiologically relevant concentrations (0.1 to 10 μM) (68), whilst 
nanomolar levels of tyrosol, caffeic acid and p-coumaric acid protect cortical neurons against 5-S-cysteinyl-
dopamine induced injury (63).  Indeed, the levels of protection induced by these phenolics was equal to, if 
not greater than, that observed for similar concentration of the flavonoids, (+)-catechin, (-)-epicatechin and 
quercetin (63).  The hydroxycinnamate, caffeic acid, has also been shown to be neuroprotective, 
counteracting inflammatory injury induced by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) by 
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decreasing the production of a number of inflammatory cytokines, down-regulating the expression of iNOS, 
COX-2 and glial fibrillary acidic protein and lowering the production of NO and PGE₂ (58).  In addition, 
caffeic acid phenethyl ester may protect cerebellar granule neurons against glutamate-induced neuronal 
death via inhibition of p38 phosphorylation and caspase-3 activation (71) and significantly prevents hypoxic-
ischaemic-induced neonatal rat brain damage in the cortex, hippocampus and thalamus (72).  
Despite these data, the impact of such phenolics on neuronal function/activity has received little attention 
relative to flavonoids, in particular in animal and human trials, and there is a lack of understanding with 
regards to their mechanisms of action in the brain in vivo.  In particular, there is no data relating to the 
consumption of small phenolics and hydroxycinnamtes, such as those present in Champagne wine on 
memory and neuro-cognitive performance.  To address this, we have investigated the potential effects of 
moderate, medium-term Champagne wine intake on age-related deficits in spatial working memory and 
motor performance and the potential mechanisms of action in the hippocampus and cortex. 
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RESULTS 
Analysis of phenolic constituents in Champagne wine 
The HPLC analysis of the phenolic extract obtained from Champagne wine allowed us to identify and 
quantify the major constituents present (Figure 1). The chromatographic profile of the organic extract at 
280nm (Figure 1A) and 320nm (Figure 1B) highlights the major phenolic components in the Champagne 
extract utilized: gallic acid (peak 1), protocatechuic acid (peak 2) tyrosol (peak 3), caftaric acid (peak 4) and 
caffeic acid (peak 5); whereas the overlapping standard runs of the flavonoids catechin (std 6), epicatechin 
(std 7) and resveratrol (std 8) indicate the absence of these compounds in the extract in detectable levels.  
The major phenolics identified (Figure 1C) were quantified in order to precisely characterize intake on 
supplementation of the Champagne intervention (Fig 1D). 
 
Food intake and animal weight: Animals were fed daily with Champagne, an iso-caloric control or an iso-
caloric alcohol containing control (Figure 1D). There were no significant differences in food intake among 
the three groups throughout the study period (iso-caloric control: 20.81 g/day; alcohol control: 20.42 g/day; 
Champagne group: 20.36 g; p>0.05).  At baseline, control, alcohol and Champagne group animals weighed 
478.11 (±18.23), 484.63 (±48.06) and 455.15 (±36.97) g, respectively, and there was no significant weight 
change throughout the intervention period in any of the groups (average weights at week 6: 480.70 ± 15.75, 
490.80 ± 50.43 and 462.19 ± 31.20 g, respectively; P>0.05).   
 
Spatial working memory:  At baseline the animals performed at an average choice accuracy of 4.25 
(±0.27) and there was no significant difference in choice accuracy between the three experimental groups 
(Figure 2).  At 6 weeks there was a reduction in the choice accuracy of both iso-caloric control group (3.50 
±0.27) and alcohol group (4.00 ±0.38) and an increase in the choice accuracy of the Champagne group 
(5.29 ±0.18).  A two-way ANOVA with repeated measures indicated that there were no significant changes 
with respect to time (F(1,20)=0.022, MSE=0.026, p=0.884), or between treatments (F(2,20)=1.863, MSE=2.734, 
p=0.181), but there was a trend to significance with regards to the interaction between treatment and time 
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(F(2,20)=2.955, MSE=3.536, p=0.075).  Bonferroni post-hoc analysis indicated that this trend to significance 
was predominantly driven by a significant difference in choice accuracy between the iso-caloric control 
group and the Champagne group at 6 weeks (P<0.01).   
 
Motor performance:  A two-way ANOVA with repeated measures indicated that there was no significant 
affect of the interventions on distance covered by the animals on beam walking tests (time: F(1,19)=1.101, 
MSE=0.621, p=0.307; treatment: F(2,19)=0.855, MSE=4.058, p=0.441; interaction: F(2,19)=1.080, 
MSE=0.609, p=0.360) (Figure 2A).  Similarly, latency time (Figure 2B) was not significantly affected by 
control or Champagne intervention for 6 weeks (time: F(1,19)=1.703, MSE=33.783, p=0.208; treatment: 
F(2,19)=0.441, MSE=36.414, p=0.650; interaction: F(2,19)=0.293, MSE=5.814, p=0.749).  In agreement with 
this, there were no significant effects of any of the treatments on calculated walking speed (Figure 2C; time: 
F(1,19)=1.742, MSE=41.637, p=0.203; treatments (F(2,19)=1.155, MSE=52.296, p=0.336; interaction: 
F(2,19)=0.690, MSE=16.500, p=0.514).  These data suggest that neither alcohol nor Champagne intervention 
had an influence on motor performance. 
 
Protein expression array: 40 hippocampal (Figure 4) and 31 cortical (Figure 5) proteins related to signal 
transduction, neuroplasticity, apoptosis and cell cycle regulation were significantly modulated (p<0.05) 
following 6 weeks of Champagne intake relative to the iso-caloric control. In both hippocampus and cortex, 
Champagne intervention modulated a range of proteins involved in the MAPK signaling and the epidermal 
growth factor receptor signaling cascade, such as p38 and phospho-Raf. In addition, in the cortex 
Champagne down-regulated the expression of some calcium-activated protein kinases (PKC a, PKC b and 
PKC g) and phospholipases C and A2.  Champagne intervention increased the expression of the myelin-
associated enzyme CNPase in the hippocampus, and a range of neuroplasticity-related proteins in both 
hippocampus and cortex (Dystrophin, plakoglobin, tryptophane hydroxylase, spectrin), whereas it down-
regulated NGFR p75 and NMDAR 2a receptors in cortex only.  Finally, Champagne supplementation also 
led to the modulation of apoptotic proteins (i.e. caspases and Bcl family proteins) and cell cycle/nuclear 
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proteins, including that of the anti-apoptotic proteins Bcl-xL and Bcl-x, and cyclin A and Cdc27 in both 
hippocampus and cortex.  Probe protein array analysis provided several new candidate proteins which were 
selected based on expression levels and role in neuronal plasticity (p38, CNPase, dystrophin and Bcl-xL), 
along with previously identified proteins BDNF, pro-BDNF, CREB, mTOR, Erk, JNK, Akt, Arc, and PKA C-
α absent in the array, for further evaluation and/or confirmation by western immunoblotting. A complete list 
of the proteins analyzed with the protein array is presented as supplementary material (Supplementary Fig. 
S1: hippocampus and Fig. S2: cortex) Supplementary Data are available online at 
www.liebertonline.com/ars). 
 
Immunoblotting:  In comparison to the isocaloric and alcohol control interventions, Champagne 
intervention led to significant increases in the hippocampal levels of phospho-p38, pCREB (Ser133) and 
BDNF  (p<0.001; p<0.05 and p<0.001 respectively) (Figure 6A). In addition, there was a significant positive 
correlation between hippocampal BDNF levels in individual animal performance on spatial memory tasks 
(R=0.613, P<0.01) (Figure 6B) and between hippocampal phospho-p38 levels and spatial performance 
(R=0.681, P<0.01).  Similarly, Champagne intervention led to the increased expression of dystrophin and 
CNPase (p<0.05 and p<0.01 respectively) (Figure 7), with significant positive correlation existing between 
spatial memory task performance and hippocampal levels of dystrophin (R=0.74, P<0.05) and CNPase 
(R=0.529, P<0.05).   
In contrast, mTOR phosphorylation and Bcl-xL were altered by both the Champagne and alcohol treatments 
(Figure 8).  Hippocampal levels of Bcl-xL were found to be significantly reduced in animals supplemented 
with both Champagne (p<0.001) and alcohol (p<0.01) compared to control, although to a greater extent in 
the Champagne group (p<0.001).  mTOR activation on the other hand was significantly higher in both 
Champagne (p<0.001) and alcohol-supplemented animals (p<0.05) compared to the iso-caloric control.  
Champagne-induced hippocampal changes in p38, CNPase, Dystrophin and Bcl-xL levels in the 
hippocampus were in agreement with that observed using antibody arrays (Figure 4).  There were no 
significant alterations in the activation state, or expression of, Akt, Arc, Erk, JNK, PKA C-α and pro-BDNF 
in the hippocampus in response to either alcohol or Champagne intervention (Table 1).   
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With regards to protein expression in the cortex, the effect on mTOR was opposite to that observed in the 
hippocampus, with both alcohol (p<0.001) and Champagne (p<0.001) intervention leading to significant 
reductions in mTOR levels relative to the isocaloric control (Figure 9).  However, in a similar manner to that 
observed in the hippocampus, both alcohol and Champagne evoked significant increases in cortical 
phospho-CREB (p<0.05).  There were no significant alterations in the activation state, or expression of, Akt, 
Arc, Bcl-xL, BDNF, CNPase, Erk, JNK, p38 and pro-BDNF in the cortex (Table 1).  
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DISCUSSION 
The development of cognitive impairment and motor deficits during aging is a complex process that begins 
in middle age, even in the absence of symptomatic neurodegenerative disease (15).  Human clinical trials 
and animal studies have identified flavonoid-rich foods and beverages as being capable of delaying the 
onset of age-related cognitive impairment (21, 22, 43, 51, 53, 65, 74).  Flavonoids present in such foods 
have been postulated to evoke protection against cognitive aging through the actions of absorbed 
flavonoids and their metabolites on neurons and glia, enhancing existing neuronal function and/or to 
stimulating neuronal regeneration (21, 27, 51, 65).  Although antioxidant mechanisms cannot be excluded 
(75), recent data sets suggest that such effects are mediated by their ability to modulate neuronal signalling 
(50, 52, 54), stimulate neurotransmitter release (23), increase cerebrovascular blood flow (14) and even 
stimulate hippocampal neurogenesis (5).  Although a large body of evidence has accumulated for flavonoid-
rich foods (27), there is less known regarding the influence of non-flavonoid phenolics on similar behavioral 
and molecular parameters.  We have previously shown that such phenolics (caffeic acid, tyrosol, p-
coumaric acid and chlorogenic acid) are capable of modulating neuronal signalling in vitro (36, 63), and 
enhance blood flow in vivo, suggesting that foods/beverages containing such components may also be 
capable of inducing cognitive improvements (67).   
Despite the well-established harmful effects of heavy alcohol intake (19), epidemiological data suggest that 
moderate wine consumption may reduce the incidence of age-related dementia, including Alzheimer’s 
disease (39, 40, 73).  Animal data support these findings, indicating that a moderate consumption of red 
wine attenuates Aβ-neuropathology in a mouse model of Alzheimer's disease (70).  In the current study we 
show that Champagne wine, which is rich in phenolics, such as gallic acid, protocatechuic acid, tyrosol, 
caftaric acid and caffeic acid, but essentially poor or free of flavonoids, is also capable of enhancing spatial 
working memory (without altering motor performance) in aged animals.  In contrast, moderate alcohol intake 
failed to induce spatial memory changes.  These observations are in agreement with those observed 
following long-term red wine intake in a similar model of hippocampal-dependent spatial memory (2).   
The effects of Champagne on spatial memory were paralleled by a number of changes in hippocampal and 
cortical protein expression, which may underpin performance on spatial memory tasks.  Perhaps most 
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notably, dystrophin and CNPase were modulated by Champagne supplementation but not alcohol.  
CNPase (2',3'-cyclic nucleotide 3'-phos phodiesterase) is a myelin-associated enzyme that constitutes 
around 4% of total CNS myelin protein, and is thought to undergo significant age-associated changes (17), 
and is reduced in Alzheimer’s disease and Down’s syndrome patients (69).  Furthermore, Champagne-
induced hippocampal increases in the cytoskeletal associated protein, dystrophin, may be beneficial as a 
lack of this protein in the hippocampus has been associated with impaired cognitive function (37), spatial 
memory (61) and long-term potentiation (60).  Indeed, patients lacking dystrophin in the hippocampus and 
neocortex (due to mutation in the dystrophin gene) display a range of cognitive deficits (1).  Intervention 
with the phenolic rich Champagne also led to the increased expression of a range of ‘other’ cytoskeletal 
proteins, including plakoglobin (γ-catenin), spectrin, calponin, cytokeratin pep4 and pep19, myosin Va and 
Focal Adhesion Kinase.  Such proteins facilitate complex neuronsal network formation in the brain and 
operate with neuronal membrane proteins (e.g., ion channels, scaffolding proteins, and adaptor proteins) 
at sites of synaptic contacts to regulate synaptogenesis and coordinate synaptic strength (16, 41).   
BDNF, a major regulator of synaptic transmission and plasticity at adult synapses (32) has previously been 
shown to partly mediate flavonoid-induced improvement in spatial memory through the ERK/Akt-CREB-
BDNF pathway (44, 74).  We show that phenolics present in Champagne also increase BDNF and CREB 
levels in the hippocampus and a number of other neuroplastic proteins, notably dystrophin, plakoglobin, 
tryptophane hydroxylase, CNPase.  CREB is well known to be involved in memory and learning processes 
(55), via its selective activation of numerous downstream genes including BDNF (3) and the CREB/BDNF 
pathway plays a critical role in synaptic plasticity and memory consolidation (35).  In contrast to previous 
findings with flavonoid-rich interventions, we observed no significant modulation of ERK1/2 or Akt by 
Champagne intervention, suggesting that BDNF is not regulated in this manner.  Rather phenolic-induced 
BDNF expression may be regulated through p38 signalling in the hippocampus, leading to a decrease in 
the ERK/p38 activity ratio and the direct inhibition of raf-1 by p38 (18).  Indeed, raf-1 was significantly down-
regulated by Champagne intervention, together with a number of other proteins connected to raf-1 in the 
hippocampus (p38, ATF2 , GADD 153, p57kip2, Cdc27, Cyclin A, E2F1, PCAF, c-myc, GRB2, FAK and 
spectrin) and in the cortex (p38, Cyclin A, Cyclin D1, c-myc, caspase 7, NGRF p75, PTEN, Phospholipase 
C g1 and A2 group V, PKC a b and g, NMDAR 2a, Pyk2 and Tau), as indicated by STRING functional 
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protein association networks (20).  Furthermore, the observed increases in p38 activation are in agreement 
with previous findings, showing that p38 activity may mediate BDNF synthesis in the rat hippocampus (24).   
Furthermore, unlike flavonoids, Champagne phenolics did not specifically regulate Akt-mTOR signalling, 
although alcohol treatment did appear to increase in the activation status of mTOR, a protein that regulates 
survival, differentiation and development of neurons and is crucial for synaptic plasticity, learning and 
memory formation in adult brain (56), something which agrees with previous datasets (30). Similarly, 
reductions in hippocampal levels of Bcl-xL levels were reduced by both Champagne and alcohol, 
suggesting that alcohol intake itself may play a role in apoptotic regulation in the brain (13).  A number of 
other apoptotic proteins were found to be significantly down-regulated by champagne in the hippocampus 
(Bcl-xL, Bcl-x, caspases 5, 6 and 11, PSR and GADD 153,) and in the cortex (Bcl-xL, Bcl-x, Bcl-10, 
caspases 7 and 11), although it is unclear whether alcohol alone would also mediate similar reductions.  
Anti-apoptotic proteins such as Bcl-xL and other members of the Bcl-2 family have been implicated in the 
selective neuronal loss observed in AD (49) and have been found to be up-regulated in Alzheimer brains 
(25). 
In summary, the potential of Champagne to beneficially influence spatial memory appears to be mediated 
by its ability to induce a number of changes in hippocampal and cortical protein expression, which occur in 
parallel to behavioral effects.  Such effects on protein expression may result via the direct actions of 
individual phenolics such as tyrosol, caffeic acid and their metabolites or their synergistic effect on 
hippocampal and cortical neurons/glia following their uptake into the brain.  Although we did not observe 
this directly, previous data support the potential for such phenolics to undergo transfer across the blood 
brain barrier (BBB) (11, 46).  Whilst the ability of flavonoids to cross the BBB is believed to be dependent 
on lipophilicity, small phenolics may transverse the BBB via amino acid transporters, such as has been 
reported for 4-ethylcatechol (34).  Furthermore, caffeic acid shares structural similarities with L-DOPA and, 
as such, may undergo BBB transport via catecholamine transporter systems. Together, our data indicate 
that moderate Champagne intake, and phenolic acid intake in general, may be beneficial in counteracting 
memory impairments associated with aging, a finding that broadly supports human epidemiological data 
(26, 28, 29, 39). 
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INNOVATION 
Flavonoid-rich foods and beverages have been shown to exert a multiplicity of neuroprotective effects in 
the brain, whereas little is known regarding the actions of smaller phenolics/polyphenols. Our data provide 
the first evidence that phenolics such as gallic acid, protocatechuic acid, tyrosol, caftaric acid and caffeic 
acid, delivered via moderate Champagne wine intake, also induce improvements in spatial memory in aged 
rodents and are dependent on the potential of these phenolics to modulate the expression of a number of 
proteins in the cortex and hippocampus related to the control of cell signaling, neuronal plasticity, cell cycle 
and apoptosis. 
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MATERIALS AND METHODS 
Materials 
Gallic acid, protocatechuic acid, caffeic acid, Bradford reagent, panorama antibody array Cell Signaling Kit, 
CelLytic™ MT Cell Lysis Reagent and HRP-conjugated goat anti-rabbit and anti-mouse secondary 
antibodies were obtained from Sigma (Poole, UK). Caftaric acid was obtained from Apin Chemicals 
(Abingdon, UK). Tyrosol was purchased from Extrasynthese (Lyon, France). PhosSTOP phosphatase 
inhibitors and cOmplete Mini protease inhibitors were obtained from Roche (Burgess Hill, UK). Precision 
Plus Protein Western C Standards and Precision Protein StrepTactin-HRP Conjugate were purchased from 
Biorad (Hemel Hempstead, UK). Primary antibodies used were: anti-BDNF (1:200) and anti-pro-BDNF 
(1:200) from Millipore (Watford, UK); anti-phospho-p38 Thr180/Tyr182 (1:1000), anti-total-p38 (1:1000), 
anti-phospho-CREB Ser133 (1:1000), anti-total-CREB (1:1000), anti-phospho-Erk1/2 Thr202/Tyr204 
(1:2000), anti-total-Erk1/2 (1:2000), anti-phospho-Akt Ser473 (1:1000), anti-total-Akt (1:1000), anti-
phospho-JNK Thr183/Tyr185 (1:1000), anti-total-JNK (1:1000), anti-Arc/Arg 3.1 C-7 (1:1000), anti-
phospho-mTOR Ser2448 (1:1000), and anti-mTOR (1:1000) from New England Biolabs (Hitchin, UK); anti-
phospho-PKA C-α (1:1000), anti-total-PKA C-α (1:1000), anti CNPase (1:1000), anti-dystrophin (1:500) and 
anti-Bcl-xL (1:500) from Sigma (Poole, UK). ECL reagent, and Hyperfilm-ECL were purchased from 
Amersham Biosciences (Amersham, UK). All other reagents were obtained from Sigma (Poole, UK) or 
Merck (Nottingham, UK). 
 
Extraction and quantification of polyphenols from Champagne Wine.  
Champagne extracts were prepared using Champagne wine derived from both Chardonnay and Pinot Noir 
and Pinot Meunier grapes as reported previously (68). Briefly, 375ml of Champagne were degassed, 
filtered, concentrated under vacuum and extracted with ethyl acetate. The organic phase was separated 
from the aqueous phase and concentrated under reduced pressure to yield a brown aromatic residue 
(yield=1g/375ml). The obtained fraction was dissolved in methanol, filtered and analyzed by HPLC. HPLC 
analysis was carried out with an Agilent 1100 series liquid chromatograph equipped with a diode array 
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detector linked to the HP ChemStation Software system. Samples were analyzed by reverse-phase HPLC 
using a Nova-Pak C18 column (4.6 × 250mm, 4 µm particle size) fitted with a guard column C18 NovaPak 
from Waters (Elstree, UK). The temperature of the column was maintained at 30°C. The mobile phases 
consisted of a mixture of aqueous methanol 5% in 0.1% hydrochloric acid 5M (A) and a mixture of aqueous 
acetonitrile 50% in 0.1% hydrochloric acid 5M (B) and were pumped through the column at 0.7 ml/min. The 
following gradient system was used (min/% B): 0/5, 5/5, 40/50, 55/100, 59,9/100, 60/5, with 10 min post-
run. The eluent was monitored by photodiode array detection at 280 and 320 nm, and spectra of products 
were obtained over the 200–600 nm range. Calibration curves of the phenolic compounds were constructed 
using authentic standards (0.1–100 mg/ml) and in each case were found to be linear with correlation 
coefficients of .0.995. All data were analyzed using ChemStation software. 
Animals and supplementation:  All procedures were conducted according to the specifications of the 
United Kingdom Animals (Scientific Procedures) Act, 1986 and to the national guidelines for the care and 
use of animals. Three groups of adult, male Wistar rats (n = 8 per group; housed in cages each containing 
2 rats; Harlan, UK) were kept, under controlled temperature (22±1°C) and humidity (50%±10%), and on a 
12:12 light-dark cycle (lights off 10:00 hours).  All rats were 15 months old at the beginning of the trial.  
Animals were pseudo-randomly assigned to 3 groups based on their baseline spatial working memory 
correct choice scores. Once allocated to a group, animals were fed daily with either Champagne, an iso-
caloric control drink or an iso-caloric drink containing alcohol (Figure 1D). The iso-caloric control was 
matched for macro- and micronutrient-content, notably glycerol, fructose, glucose and citric acid content 
and was dissolved in carbonated water. The alcohol control was similarly matched but also contained 
alcohol (12.5% vol). The Champagne wine used in the study also contained phenolic compounds (gallic 
acid, protocatechuic acid, tyrosol, caftaric acid, caffeic acid). To control daily intake of the intervention diets, 
the three drinks were prepared freshly each day and administered in the form of a mash, by mixing the test 
solutions with a small amount (8g/10ml) of powdered standard diet (RM3, Special Diets Services, UK), and 
the correct amount given to each rat based on body weight.  The level of Champagne and alcohol 
supplementation was approximately equivalent to a glass per day for human consumption (1.78 ml/kg bw).  
At the end of the spatial memory trials animals were sacrificed and brains removed, the hippocampal and 
cortical regions dissected, snap-frozen in liquid nitrogen, and stored at – 80 °C until analysis.  
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Spatial working memory:  Spatial working memory performance was assessed using a cross-maze 
apparatus (38), which is a commonly used paradigm to evaluate spatial learning, working memory and 
reference memory performance in rodents (48, 74).  All rats were fasted overnight before the procedure to 
provide sufficient motivation to ensure a high level of response during testing.  Extra-maze cues (laboratory 
furniture, lights, and several prominent visual features on the walls) were held constant throughout the 
experiment.  Rats were given 2 weeks pre-training (habituation) in order that they ran reliably from the start 
arm to locate reward pellets in both goal arms of the maze.  This was followed by 6 weeks of shaping 
sessions (each consisting of six trials) prior to initiation of the supplementation regimes.  During each 
shaping trial, rats were trained to enter an open goal arm and collect a reward pellet (entry to the alternate 
other goal arm was restricted).  Across each shaping session, the open goal arm varied between trials 
according to a pseudorandom design. Following completion of the shaping sessions, dietary 
supplementation and testing sessions were started. During the testing phase, each animal received 8 trials 
per test session, with each consisting of a sample phase and a choice phase.  During the sample phase, 
rats were placed in the start arm and allowed access only one goal arm to recover a food reward.  Once 
the reward pellet had been collected, animals were removed and returned to the start arm for 10 s.  During 
the choice phase, both goal arms were accessible and animals were allowed a free choice between the 
two, with correct choice responses recorded for animals entering arm not visited during the sample phase.  
An animal was deemed to have selected an arm when it had placed a hind foot within the confines of the 
arm correct arm (retracing was measured as a failure on the task).  Correct choices were rewarded with a 
food reward, whereas incorrect arm choices meant the animal was returned to its home cage.  For 50% of 
the choice phases the rat was placed in the “alternate” start arm opposite to the normal start arm.  For each 
trial, accuracy and time taken to make a choice were measured. The maze was cleaned with 50% ethanol 
solution between trials to remove any olfactory clues.  Each test session contained a pseudo-random 
sequence of correct choices between the two arms, as well as a pseudo-random sequence for the start 
arm during the choice phase.  Rats were given 2 test sessions on the cross-maze, one session administered 
immediately before supplementation was started (baseline) and one administered at 6 weeks. Each group 
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of aged animals was pseudo-randomly assigned before the intervention based on baseline correct choices 
scores. 
 
Stationary beam test:  The motor skills of the animals during champagne supplementation were tested on 
a stationary beam (57) at baseline and at the end of the intervention (6 weeks). The dynamic equilibrium 
was tested on a beam consisting of a scale (150 cm, 3cm diameter) located 40 cm above a soft carpet. At 
the beginning of the experiment, the rat was placed on the middle of the beam, its body axis perpendicular 
to the beam’s longitudinal axis. Distance covered and latency times before falling were recorded, and the 
walking speed was calculated. The trial was stopped when the animal fell or 3 mins had elapsed. 
 
Antibody array: The Panorama Antibody array Cell Signalling Kit (Sigma-Aldrich) was used, which 
contains 224 different antibodies spotted in duplicate on nitrocellulose glass slides, and represents proteins 
involved in biological pathways such as apoptosis, cell cycle, nuclear proteins, neurobiology, cytoskeleton 
and signal transduction. Three biological replicates were used for hippocampus region and two biological 
replicates for cortex region. Statistical analysis was conducted on biological replicates and significantly 
modulated protein expression in the hippocampus and in the cortex was reported in table 1 and table 2 
respectively.   Proteins from both brain regions of champagne-treated and control-treated animals were 
extracted, purified, labeled with Cy-fluorescent dyes, hybridized to microarrays (at concentration of 5 µg/ml 
of each labeled target) and washed according to the protocols provided by the manufacturer. Briefly, protein 
extracts were prepared using the extraction buffer provided in the kit, and protein concentration was 
determined in the supernatant by the Bradford method. 1 mg of protein extract from each sample was 
labelled with Cy5 or Cy3, according to the manufacturer’s instructions. Free, non-incorporated Cy3 and Cy5 
dyes were separated by applying the labeled extracts on SigmaSpin Post-Reaction Clean-Up Columns. 
The dye to protein molar ratio (D/P) was calculated and only samples having D/P > 2 were used. An equal 
amount of labeled protein of both extracts (5µg/ml) was incubated on the Microarray slide for 30 min; all 
washes were done in PBS-Tween 0.05%. Microarray slides were scanned on GenePix 4200 Professional 
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scanner (Molecular Devices), with laser power reduced to 25% and PMT settings manually adjusted to 
avoid saturated pixels in the experimental spots, and resulted images were analyzed with GenePixPro 6 
software (Molecular Devices). Spot intensities were local background adjusted, and spots with negative 
values were removed from further analysis. For remaining spots, resulted intensities were averaged for 
replicates, treatment-to-control ratios calculated, log2-transformed and normalized to median.  
 
Western immunoblotting:  Dissected brain regions were homogenized on ice with a glass homogenizer 
using CelLytic™ MT Cell Lysis Reagent (Sigma, UK) containing cOmplete Mini protease inhibitors and 
PhosSTOP phosphatase inhibitors. Homogenates were left on ice for 45 min before centrifugation at 4000 
g for 5 min at 4 °C to remove unbroken cell debris and nuclei. Protein concentration in the supernatants 
was determined by the Bradford protein assay. Samples were incubated for 2 min at 95 °C in boiling buffer 
(final concentration 62.5 mM Tris, pH 6.8, 2% SDS, 5% 2-mercaptoethanol, 10% glycerol, and 0.0025% 
bromophenol blue). Boiled samples (20–60 μg/lane) and protein standards were run on 9–12% SDS-
polyacrylamide gels and proteins were transferred to nitrocellulose membranes (Hybond-ECL; Amersham) 
by semidry electroblotting (1.5 mA/cm2). The nitrocellulose membrane was then incubated in a blocking 
buffer (20 mM Tris, pH 7.5, 150 mM NaCl; TBS) containing 4% (w/v) skimmed milk powder for 45 min at 
room temperature followed by 2 × 5 min washes in TBS supplemented with 0.05% (v/v) Tween 20 (TTBS). 
Blots were then incubated with the primary antibodies of interest (1:200 - 1:2000 dilution) in TTBS 
containing 1% (w/v) skimmed milk powder (antibody buffer) overnight at 4°C on a three-dimensional rocking 
table. The blots were washed 2 × 10 min in TTBS and incubated with secondary anti-rabbit or anti-mouse 
IgG conjugated to HRP (1:1000 dilution) and Precision Protein StrepTactin-HRP Conjugate (1:10.000 
dilution) for 45 min. Finally blots were washed 2 × 10 min in TTBS rinsed in TBS and exposed to ECL 
reagent for 1–2 min and developed. Bands were analyzed using Bio-Rad Quantity One 1-D Analysis 
software. Molecular weights of the bands were calculated from comparison with pre-stained molecular 
weight markers that were run in parallel with the samples. Relative band intensities were calculated as a 
ratio of the phosphorylated protein to total protein in the case of CREB, p38 and mTOR. For BDNF, 
dystrophin, CNPase and Bcl-xL, relative band intensity was calculated in comparison to GAPDH levels. 
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Statistics: All behavioral data (means ± SEM, n=8) were subjected to two-way analysis of variance for 
repeated measures with diet group (control, alcohol and champagne) and time (0, 6 weeks) as main factors, 
followed by a Bonferroni post-hoc test to examine differences between individual treatments (GraphPad 
Prism 5). For the microarray data (means ± SEM, n=3 for hippocampus, n=2 for cortex), to evaluate the 
difference in protein expression between champagne-treated and iso-caloric control-treated samples, we 
used Rank Product Test (4), as implemented in MeV 4.6 microarray data analysis software (45), with cut-
off of log2-ratio more than 0.4 or less then -0.4 (more than 1.3-fold change) and P<0.05. For the western 
immunoblotting data, (means ± SEM, n≥3) the statistical evaluation of the results was performed by one-
way analysis of variance (ANOVA) followed by a Student-Newman-Keuls post-hoc t-test (GraphPad Prism 
5). Significant changes are indicated as follows: a = P< 0.001; b = P< 0.01; c = P< 0.05. Correlations 
between animal performance on spatial memory tasks and protein levels in the brain were calculated using 
the Pearson product moment correlation coefficient and the associated P value. 
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LIST OF ABBREVIATIONS 
Akt = Akt/Protein kinase B 
Arc = Activity-regulated cytoskeleton-associated protein 
ATF2 = Activating Transcription Factor 2 
BBB = Blood Brain Barrier 
Bcl-x = B-cell lymphoma 2–associated x protein 
Bcl-xL  = B-cell lymphoma2-extra large protein 
BDNF = Brain-Derived Neurotrophic Factor 
Cdc27 = Cell division cycle protein 27 
c-myc = Myc proto-oncogene protein 
CNPase = 2',3'-cyclic-nucleotide 3'-phosphodiesterase 
CNS = Central Nervous System 
COX-2 = Cyclooxygenase-2 
CREB = cAMP response element-binding protein 
E2F1 = Transcription factor E2F1 
Erk = Extracellular-signal-regulated kinase 
FAK = Focal Adhesion Kinase 
GADD 153 = Growth arrest and DNA damage-inducible protein 153 
GRB2 = Growth factor receptor-bound protein 2 
iNOS = Inducible Nitric Oxide Synthase 
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JNK = c-Jun Amino-terminal Kinases 
L-DOPA = L-3,4-dihydroxyphenylalanine 
MAPK = mitogen-activated protein kinase 
MPTP = 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine 
mTOR = mammalian target of rapamycin 
NGFR p75 = p75 Nerve Growth Factor Receptor, low affinity 
NMDAR 2a = N-methyl-D-aspartate Receptor 2a 
NO = Nitric Oxide 
p38 = Mitogen-activated protein kinase 14 (p38 alpha) 
p57kip2 = cyclin-dependent kinase inhibitor 1C, p57 isoform 1 
PCAF = P300/CBP-associated factor 
PGE2 = Prostaglandin E2 
PKA C-α = cAMP-dependent protein kinase catalytic subunit alpha 
PKC a = Protein kinase C alpha 
PKC b = Protein kinase C beta 
PKC g = Protein kinase C gamma 
pro-BDNF = Brain-Derived Neurotrophic Factor precursor 
PSR = Phosphatidylserine Receptor 
PTEN = Phosphatase and tensin homolog 
Pyk2 = Protein tyrosine kinase 2 
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raf-1 = RAF proto-oncogene serine/threonine-protein kinase 
STRING = Search Tool for the Retrieval of Interacting Genes/Proteins 
Tau = microtubule-associated protein tau 
  
Corona et al. 
 
24 
 
REFERENCES 
1. Anderson JL, Head SI, Rae C, and Morley JW. Brain function in Duchenne muscular dystrophy. 
Brain 125: 4-13, 2002. 
2. Assuncao M, Santos-Marques MJ, de Freitas V, Carvalho F, Andrade JP, Lukoyanov NV, and 
Paula-Barbosa MM. Red wine antioxidants protect hippocampal neurons against ethanol-induced damage: 
a biochemical, morphological and behavioral study. Neuroscience 146: 1581-1592, 2007. 
3. Bramham CR, and Messaoudi E. BDNF function in adult synaptic plasticity: the synaptic 
consolidation hypothesis. Prog Neurobiol 76: 99-125, 2005. 
4. Breitling R, Armengaud P, Amtmann A, and Herzyk P. Rank products: a simple, yet powerful, new 
method to detect differentially regulated genes in replicated microarray experiments. FEBS Lett 573: 83-
92, 2004. 
5. Casadesus G, Shukitt-Hale B, Stellwagen HM, Zhu X, Lee HG, Smith MA, and Joseph JA. 
Modulation of hippocampal plasticity and cognitive behavior by short-term blueberry supplementation in 
aged rats. Nutr Neurosci 7: 309-316, 2004. 
6. Chamkha M, Cathala B, Cheynier V, and Douillard R. Phenolic composition of champagnes from 
Chardonnay and Pinot Noir vintages. J Agric Food Chem 51: 3179-3184, 2003. 
7. Chan SL, Capdeville-Atkinson C, and Atkinson J. Red wine polyphenols improve endothelium-
dependent dilation in rat cerebral arterioles. J Cardiovasc Pharmacol 51: 553-558, 2008. 
8. Chan SL, Tabellion A, Bagrel D, Perrin-Sarrado C, Capdeville-Atkinson C, and Atkinson J. Impact 
of chronic treatment with red wine polyphenols (RWP) on cerebral arterioles in the spontaneous 
hypertensive rat. J Cardiovasc Pharmacol 51: 304-310, 2008. 
9. Constant J. Alcohol, ischemic heart disease, and the French paradox. Coron Artery Dis 8: 645-649, 
1997. 
10. Corder R. Red wine, chocolate and vascular health: developing the evidence base. Heart 94: 821-
823, 2008. 
Corona et al. 
 
25 
11. D'Angelo S, Manna C, Migliardi V, Mazzoni O, Morrica P, Capasso G, Pontoni G, Galletti P, and 
Zappia V. Pharmacokinetics and metabolism of hydroxytyrosol, a natural antioxidant from olive oil. Drug 
Metab Dispos 29: 1492-1498, 2001. 
12. Dal-Ros S, Bronner C, Auger C, and Schini-Kerth VB. Red wine polyphenols improve an 
established aging-related endothelial dysfunction in the mesenteric artery of middle-aged rats: role of 
oxidative stress. Biochem Biophys Res Commun 419: 381-387, 2012. 
13. Freund G. Apoptosis and gene expression: perspectives on alcohol-induced brain damage. Alcohol 
11: 385-387, 1994. 
14. Ghosh D, and Scheepens A. Vascular action of polyphenols. Mol Nutr Food Res 53: 322-331, 2009. 
15. Glisky EL. Changes in Cognitive Function in Human Aging. In: Brain Aging: Models, Methods, and 
Mechanisms, edited by Riddle DR. Boca Raton (FL): CRC Press, 2007. 
16. Goda Y. Cadherins communicate structural plasticity of presynaptic and postsynaptic terminals. 
Neuron 35: 1-3, 2002. 
17. Hayakawa N, Kato H, and Araki T. Age-related changes of astorocytes, oligodendrocytes and 
microglia in the mouse hippocampal CA1 sector. Mech Ageing Dev 128: 311-316, 2007. 
18. Hutchison MR. BDNF Alters ERK/p38 MAPK Activity Ratios to Promote Differentiation in Growth 
Plate Chondrocytes. Mol Endocrinol 26: 1406-1416, 2012. 
19. Hvidtfeldt UA, Frederiksen ME, Thygesen LC, Kamper-Jorgensen M, Becker U, and Gronbaek M. 
Incidence of cardiovascular and cerebrovascular disease in Danish men and women with a prolonged 
heavy alcohol intake. Alcohol Clin Exp Res 32: 1920-1924, 2008. 
20. Jensen LJ, Kuhn M, Stark M, Chaffron S, Creevey C, Muller J, Doerks T, Julien P, Roth A, 
Simonovic M, Bork P, and von Mering C. STRING 8--a global view on proteins and their functional 
interactions in 630 organisms. Nucleic Acids Res 37: D412-416, 2009. 
21. Joseph J, Cole G, Head E, and Ingram D. Nutrition, brain aging, and neurodegeneration. J Neurosci 
29: 12795-12801, 2009. 
22. Joseph JA, Shukitt-Hale B, and Casadesus G. Reversing the deleterious effects of aging on 
neuronal communication and behavior: beneficial properties of fruit polyphenolic compounds. Am J Clin 
Nutr 81: 313S-316S, 2005. 
Corona et al. 
 
26 
23. Joseph JA, Shukitt-Hale B, Denisova NA, Bielinski D, Martin A, McEwen JJ, and Bickford PC. 
Reversals of age-related declines in neuronal signal transduction, cognitive, and motor behavioral deficits 
with blueberry, spinach, or strawberry dietary supplementation. J Neurosci 19: 8114-8121, 1999. 
24. Katoh-Semba R, Kaneko R, Kitajima S, Tsuzuki M, Ichisaka S, Hata Y, Yamada H, Miyazaki N, 
Takahashi Y, and Kato K. Activation of p38 mitogen-activated protein kinase is required for in vivo brain-
derived neurotrophic factor production in the rat hippocampus. Neuroscience 163: 352-361, 2009. 
25. Kitamura Y, Shimohama S, Kamoshima W, Ota T, Matsuoka Y, Nomura Y, Smith MA, Perry G, 
Whitehouse PJ, and Taniguchi T. Alteration of proteins regulating apoptosis, Bcl-2, Bcl-x, Bax, Bak, Bad, 
ICH-1 and CPP32, in Alzheimer's disease. Brain Res 780: 260-269, 1998. 
26. Krenz M, and Korthuis RJ. Moderate ethanol ingestion and cardiovascular protection: from 
epidemiologic associations to cellular mechanisms. J Mol Cell Cardiol 52: 93-104, 2012. 
27. Lamport DJ, Dye L, Wightman JD, and Lawton CL. The effects of flavonoid and other polyphenol 
consumption on cognitive performance: A systematic research review of human experimental and 
epidemiological studies. Nutrition and Aging 1: 5-25, 2012. 
28. Lemeshow S, Letenneur L, Dartigues JF, Lafont S, Orgogozo JM, and Commenges D. Illustration 
of analysis taking into account complex survey considerations: the association between wine consumption 
and dementia in the PAQUID study. Personnes Ages Quid. Am J Epidemiol 148: 298-306, 1998. 
29. Letenneur L. Risk of dementia and alcohol and wine consumption: a review of recent results. Biol 
Res 37: 189-193, 2004. 
30. Li Q, and Ren J. Chronic alcohol consumption alters mammalian target of rapamycin (mTOR), 
reduces ribosomal p70s6 kinase and p4E-BP1 levels in mouse cerebral cortex. Exp Neurol 204: 840-844, 
2007. 
31. Liu P, Kemper LJ, Wang J, Zahs KR, Ashe KH, and Pasinetti GM. Grape seed polyphenolic extract 
specifically decreases abeta*56 in the brains of Tg2576 mice. J Alzheimers Dis 26: 657-666, 2011. 
32. Lu Y, Christian K, and Lu B. BDNF: a key regulator for protein synthesis-dependent LTP and long-
term memory? Neurobiol Learn Mem 89: 312-323, 2008. 
33. Manach C, Scalbert A, Morand C, Remesy C, and Jimenez L. Polyphenols: food sources and 
bioavailability. Am J Clin Nutr 79: 727-747, 2004. 
Corona et al. 
 
27 
34. Meiergerd SM, and Schenk JO. Striatal transporter for dopamine: catechol structure-activity studies 
and susceptibility to chemical modification. J Neurochem 62: 998-1008, 1994. 
35. Monti B, Berteotti C, and Contestabile A. Dysregulation of memory-related proteins in the 
hippocampus of aged rats and their relation with cognitive impairment. Hippocampus 15: 1041-1049, 2005. 
36. Mubarak A, Bondonno CP, Liu AH, Considine MJ, Rich L, Mas E, Croft KD, and Hodgson J. Acute 
effects of chlorogenic acid on nitric oxide status, endothelial function and blood pressure in healthy 
volunteers: a randomised trial. J Agric Food Chem, 2012. 
37. Muntoni F, Mateddu A, and Serra G. Passive avoidance behaviour deficit in the mdx mouse. 
Neuromuscul Disord 1: 121-123, 1991. 
38. Olton DS. The radial arm maze as a tool in behavioral pharmacology. Physiol Behav 40: 793-797, 
1987. 
39. Orgogozo JM, Dartigues JF, Lafont S, Letenneur L, Commenges D, Salamon R, Renaud S, and 
Breteler MB. Wine consumption and dementia in the elderly: a prospective community study in the 
Bordeaux area. Rev Neurol (Paris) 153: 185-192, 1997. 
40. Panza F, Capurso C, D'Introno A, Colacicco AM, Frisardi V, Lorusso M, Santamato A, Seripa D, 
Pilotto A, Scafato E, Vendemiale G, Capurso A, and Solfrizzi V. Alcohol drinking, cognitive functions in 
older age, predementia, and dementia syndromes. J Alzheimers Dis 17: 7-31, 2009. 
41. Priel A, Tuszynski JA, and Woolf NJ. Neural cytoskeleton capabilities for learning and memory. J 
Biol Phys 36: 3-21, 2009. 
42. Rainey-Smith S, Schroetke LW, Bahia P, Fahmi A, Skilton R, Spencer JP, Rice-Evans C, Rattray 
M, and Williams RJ. Neuroprotective effects of hesperetin in mouse primary neurones are independent of 
CREB activation. Neurosci Lett 438: 29-33, 2008. 
43. Rendeiro C, Spencer JP, Vauzour D, Butler LT, Ellis JA, and Williams CM. The impact of flavonoids 
on spatial memory in rodents: from behaviour to underlying hippocampal mechanisms. Genes Nutr, 2009. 
44. Rendeiro C, Vauzour D, Kean RJ, Butler LT, Rattray M, Spencer JP, and Williams CM. Blueberry 
supplementation induces spatial memory improvements and region-specific regulation of hippocampal 
BDNF mRNA expression in young rats. Psychopharmacology (Berl), 2012. 
Corona et al. 
 
28 
45. Saeed AI, Bhagabati NK, Braisted JC, Liang W, Sharov V, Howe EA, Li J, Thiagarajan M, White 
JA, and Quackenbush J. TM4 microarray software suite. Methods Enzymol 411: 134-193, 2006. 
46. Serra A, Rubio L, Borras X, Macia A, Romero MP, and Motilva MJ. Distribution of olive oil phenolic 
compounds in rat tissues after administration of a phenolic extract from olive cake. Mol Nutr Food Res 56: 
486-496. 
47. Shukitt-Hale B, Cheng V, and Joseph JA. Effects of blackberries on motor and cognitive function 
in aged rats. Nutr Neurosci 12: 135-140, 2009. 
48. Shukitt-Hale B, McEwen JJ, Szprengiel A, and Joseph JA. Effect of age on the radial arm water 
maze-a test of spatial learning and memory. Neurobiol Aging 25: 223-229, 2004. 
49. Smale G, Nichols NR, Brady DR, Finch CE, and Horton WE, Jr. Evidence for apoptotic cell death 
in Alzheimer's disease. Exp Neurol 133: 225-230, 1995. 
50. Spencer JP. Beyond antioxidants: the cellular and molecular interactions of flavonoids and how 
these underpin their actions on the brain. Proc Nutr Soc 69: 244-260, 2010. 
51. Spencer JP. The impact of flavonoids on memory: physiological and molecular considerations. 
Chem Soc Rev 38: 1152-1161, 2009. 
52. Spencer JP. The impact of fruit flavonoids on memory and cognition. Br J Nutr 104 Suppl 3: S40-
47, 2010. 
53. Spencer JP. The impact of fruit flavonoids on memory and cognition. Br J Nutr 104 Suppl 3: S40-
47. 
54. Spencer JP, Vauzour D, and Rendeiro C. Flavonoids and cognition: the molecular mechanisms 
underlying their behavioural effects. Arch Biochem Biophys 492: 1-9, 2009. 
55. Sun CY, Qi SS, Lou XF, Sun SH, Wang X, Dai KY, Hu SW, and Liu NB. Changes of learning, 
memory and levels of CaMKII, CaM mRNA, CREB mRNA in the hippocampus of chronic multiple-stressed 
rats. Chin Med J (Engl) 119: 140-147, 2006. 
56. Swiech L, Perycz M, Malik A, and Jaworski J. Role of mTOR in physiology and pathology of the 
nervous system. Biochim Biophys Acta 1784: 116-132, 2008. 
57. Thouvarecq R, Protais P, Jouen F, and Caston J. Influence of cholinergic system on motor learning 
during aging in mice. Behav Brain Res 118: 209-218, 2001. 
Corona et al. 
 
29 
58. Tsai SJ, Chao CY, and Yin MC. Preventive and therapeutic effects of caffeic acid against 
inflammatory injury in striatum of MPTP-treated mice. Eur J Pharmacol 670: 441-447, 2011. 
59. Vafeiadou K, Vauzour D, and Spencer JP. Neuroinflammation and its modulation by flavonoids. 
Endocr Metab Immune Disord Drug Targets 7: 211-224, 2007. 
60. Vaillend C, Billard JM, and Laroche S. Impaired long-term spatial and recognition memory and 
enhanced CA1 hippocampal LTP in the dystrophin-deficient Dmd(mdx) mouse. Neurobiol Dis 17: 10-20, 
2004. 
61. Vaillend C, and Ungerer A. Behavioral characterization of mdx3cv mice deficient in C-terminal 
dystrophins. Neuromuscul Disord 9: 296-304, 1999. 
62. Valls-Pedret C, Lamuela-Raventos RM, Medina-Remon A, Quintana M, Corella D, Pinto X, 
Martinez-Gonzalez MA, Estruch R, and Ros E. Polyphenol-rich foods in the Mediterranean diet are 
associated with better cognitive function in elderly subjects at high cardiovascular risk. J Alzheimers Dis 
29: 773-782, 2012. 
63. Vauzour D, Corona G, and Spencer JP. Caffeic acid, tyrosol and p-coumaric acid are potent 
inhibitors of 5-S-cysteinyl-dopamine induced neurotoxicity. Arch Biochem Biophys 501: 106-111, 2010. 
64. Vauzour D, Houseman EJ, George TW, Corona G, Garnotel R, Jackson KG, Sellier C, Gillery P, 
Kennedy OB, Lovegrove JA, and Spencer JP. Moderate Champagne consumption promotes an acute 
improvement in acute endothelial-independent vascular function in healthy human volunteers. Br J Nutr 
103: 1168-1178, 2010. 
65. Vauzour D, and Minihane AM. Neuroinflammation and the APOε genotype: Implications for 
Alzheimer's disease and modulation by dietary flavonoids and n-3 polyunsaturated fatty acids. Nutrition and 
Aging 1: 41-53, 2012. 
66. Vauzour D, Ravaioli G, Vafeiadou K, Rodriguez-Mateos A, Angeloni C, and Spencer JP. 
Peroxynitrite induced formation of the neurotoxins 5-S-cysteinyl-dopamine and DHBT-1: implications for 
Parkinson's disease and protection by polyphenols. Arch Biochem Biophys 476: 145-151, 2008. 
67. Vauzour D, Rodriguez-Mateos A, Corona G, Oruna-Concha MJ, and Spencer JP. Polyphenols and 
human health: prevention of disease and mechanisms of action. Nutrients 2: 1106-1131, 2010. 
Corona et al. 
 
30 
68. Vauzour D, Vafeiadou K, Corona G, Pollard SE, Tzounis X, and Spencer JP. Champagne wine 
polyphenols protect primary cortical neurons against peroxynitrite-induced injury. J Agric Food Chem 55: 
2854-2860, 2007. 
69. Vlkolinsky R, Cairns N, Fountoulakis M, and Lubec G. Decreased brain levels of 2',3'-cyclic 
nucleotide-3'-phosphodiesterase in Down syndrome and Alzheimer's disease. Neurobiol Aging 22: 547-
553, 2001. 
70. Wang J, Ho L, Zhao Z, Seror I, Humala N, Dickstein DL, Thiyagarajan M, Percival SS, Talcott ST, 
and Pasinetti GM. Moderate consumption of Cabernet Sauvignon attenuates Abeta neuropathology in a 
mouse model of Alzheimer's disease. FASEB J 20: 2313-2320, 2006. 
71. Wei X, Ma Z, Fontanilla CV, Zhao L, Xu ZC, Taggliabraci V, Johnstone BH, Dodel RC, Farlow MR, 
and Du Y. Caffeic acid phenethyl ester prevents cerebellar granule neurons (CGNs) against glutamate-
induced neurotoxicity. Neuroscience 155: 1098-1105, 2008. 
72. Wei X, Zhao L, Ma Z, Holtzman DM, Yan C, Dodel RC, Hampel H, Oertel W, Farlow MR, and Du 
Y. Caffeic acid phenethyl ester prevents neonatal hypoxic-ischaemic brain injury. Brain 127: 2629-2635, 
2004. 
73. Weyerer S, Schaufele M, Wiese B, Maier W, Tebarth F, van den Bussche H, Pentzek M, Bickel H, 
Luppa M, and Riedel-Heller SG. Current alcohol consumption and its relationship to incident dementia: 
results from a 3-year follow-up study among primary care attenders aged 75 years and older. Age Ageing 
40: 456-463, 2011. 
74. Williams CM, El Mohsen MA, Vauzour D, Rendeiro C, Butler LT, Ellis JA, Whiteman M, and 
Spencer JP. Blueberry-induced changes in spatial working memory correlate with changes in hippocampal 
CREB phosphorylation and brain-derived neurotrophic factor (BDNF) levels. Free Radic Biol Med 45: 295-
305, 2008. 
75. Willis LM, Shukitt-Hale B, and Joseph JA. Modulation of cognition and behavior in aged animals: 
role for antioxidant- and essential fatty acid-rich plant foods. Am J Clin Nutr 89: 1602S-1606S, 2009. 
 
 
  
Corona et al. 
 
31 
TABLES 
Table 1. Immunoblotting analysis of proteins extracted from hippocampus and cortex 
  Control  Champagne  Alcohol  
  mean SEM mean SEM mean SEM 
Hippocampus             
Akt ph/tot 0.581 0.023 0.535 0.009 0.543 0.004 
Arc/GAPDH 0.722 0.130 0.684 0.214 0.803 0.059 
Erk1 ph/tot 0.271 0.009 0.260 0.016 0.248 0.019 
Erk2 ph/tot 0.116 0.003 0.120 0.013 0.101 0.008 
JNK 1 ph/tot 0.949 0.064 1.043 0.111 0.853 0.010 
JNK 2/3 ph/tot 0.672 0.035 0.666 0.057 0.598 0.043 
PKA C-α ph/tot 0.022 0.015 0.017 0.008 0.044 0.015 
pro-BDNF/GAPDH 0.372 0.050 0.517 0.048 0.284 0.081 
Cortex             
Akt ph/tot 0.782 0.011 0.734 0.024 0.732 0.025 
Arc/GAPDH 0.577 0.050 0.648 0.010 0.598 0.028 
Bcl-xL/GAPDH 0.536 0.081 0.680 0.077 0.693 0.042 
BDNF/GAPDH 1.000 0.034 0.995 0.075 0.803 0.089 
CNPase/GAPDH ratio 1.413 0.144 1.915 0.183 1.662 0.064 
Erk1 ph/tot 0.955 0.177 0.731 0.043 0.845 0.041 
Erk2 ph/tot 0.682 0.120 0.586 0.032 0.673 0.024 
JNK 1 ph/tot 0.880 0.014 0.917 0.013 0.921 0.012 
JNK 2/3 ph/tot 0.757 0.030 0.744 0.107 0.757 0.013 
p38 ph/tot 0.732 0.077 0.903 0.002 0.593 0.086 
pro-BDNF/GAPDH 0.500 0.032 0.586 0.050 0.302 0.109 
Statistical analysis (One-way ANOVA) was performed. Differences were all non-significant ( p>0.05). 
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Figure 1 
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Figure 3 
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Figure 4 
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Figure 5 
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Figure 6 
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Figure 7 
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Figure 8 
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Figure 9 
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FIGURE LEGENDS 
Figure 1. Major constituents of the control and test interventions. Chromatographic separation of the 
aqueous/organic extract of Champagne wine at: (A) 280nm and (B) 320nm indicating quantified phenolics 
in the extract (1 to 5) and flavonoid standards of epicatechin (6) catechin (7) and resveratrol (8) to point out 
their absence in the extract. (C): Structures of major phenolic compounds present: 1: gallic acid; 2: 
protocatechuic acid; 3: tyrosol; 4: caftaric acid; 5: caffeic acid. (D) Quantification of phenolic compounds 
and of other major constituents of the control and test interventions. 
Figure 2. Effect of Champagne supplementation on rat’s spatial memory performance measured as choice 
accuracy (number of correct choices) in a T maze alternation task. Maximum score is 8 correct choices. 
Results are presented as means ±SEM (n=8). Two-way ANOVA indicated a trend to significance on the 
interaction between treatment and time (F3.536=2.955, p=0.075) and Bonferroni post-hoc test indicated a 
significant effect of Champagne vs control at 6 weeks (b = P<0.01).  
Figure 3. Effect of Champagne supplementation on rat’s motor skills (stationary beam scores) in 
champagne supplemented animals (A) Distance. (B) Latency time. (C) walking speed. Results are 
presented as means ±SEM (n=8). No significant differences were found (two-way ANOVA). 
Figure 4. Differentially expressed proteins (antibody array) in the hippocampus between Champagne and 
control treated animals. Results are presented as mean log2-ratios ±SD (n=4). All changes were statistically 
significant (p<0.05). 
Figure 5. Differentially expressed proteins (antibody array) in the cortex between champagne and control 
treated animals. Results are presented as mean log2-ratios ±SD (n=4). All changes were statistically 
significant (p<0.05). 
Figure 6. Immunoblotting analysis of proteins extracted from hippocampus. (A) Crude lysates (20-40µg 
protein) were immunoblotted with antibodies that specifically recognize phospho-p38, total-p38, phospho-
CREB, total-CREB, BDNF, and GAPDH. Results (phospho/total ratio for p38 and CREB; protein/GAPDH 
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ratio for BDNF) are presented as means ± SEM (n ≥ 6). a = p < 0.001; c = p < 0.05 represent significant 
differences vs control (One-way ANOVA). (B) Correlation between choice accuracy in spatial memory task 
and hippocampal BDNF protein levels, after 6 weeks of dietary interventions, ( n=19; r=0.613; P<0.01). 
Figure 7. Immunoblotting analysis of proteins extracted from hippocampus. Crude lysates (20-40µg protein) 
were immunoblotted with antibodies that specifically recognize dystrophin, CNPase and GAPDH. Results 
(protein/GAPDH ratios) are presented as means ± SEM (n ≥ 6). b = p < 0.01; c = p < 0.05 represent 
significant differences vs control (One-way ANOVA). 
Figure 8. Immunoblotting analysis of proteins extracted from hippocampus. Crude lysates (20-40µg protein) 
were immunoblotted with antibodies that specifically recognize phospho-mTOR, total-mTOR, Bcl-xL and 
GAPDH. Results (phospho/total ratio for mTOR; protein/GAPDH ratio for Bcl-xL) are presented as means 
± SEM (n ≥ 3). a = p < 0.001; b = p < 0.01; c = p < 0.05 represent significant differences vs control. A = p < 
0.001 represent significant differences vs alcohol (One-way ANOVA). 
Figure 9. Immunoblotting analysis of proteins extracted from cortex. (A) Crude cortical lysates (20-40µg 
protein) were immunoblotted with antibodies that specifically recognize phospho-mTOR, total-mTOR, 
phospho-CREB and total CREB. Results (phospho/total ratio for mTOR; protein/GAPDH ratio for CREB) 
are presented as means ± SEM (n ≥ 3). a = p < 0.001; c = p < 0.05 represent significant differences vs. 
control (One-way ANOVA). 
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